Skip to content

SIRON: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SIRON

BE 0894.616.251
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€9,494
2024 · -€5,063-€4,431
Equity
€10,215
2024 · €19,709-€9,494
Cash
€9,553
2024 · €19,186-€9,633
Balance sheet total
€10,632
2024 · €19,709-€9,077

Largest movements

2024 to 2025
Assets
  • Cash -€9,633

    down €9,633 (-50.2%), from €19,186 to €9,553

    mainly Net result for the year (-€9,494) and Receivables within one year (-€556)

  • Receivables within one year +€556

    up €556 (+106%), from €523 to €1,079

Equity and liabilities
  • Profit (loss) carried forward -€8,634

    down €8,634, from €249 to -€8,385

  • Reserves -€860

    no longer reported in 2025 (was €860)

  • Trade debts +€417

    new in 2025: €417

Income statement
  • Gross operating margin -€4,379

    down €4,379 (-102%), from -€4,289 to -€8,668

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€5,063
Gross operating margin -€4,379
Other operating charges -€19
Financial charges -€34
Result 2025 -€9,494
lowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€9,633
Investment €0
Financing €0
Cash 2024 €19,186
Net result for the year -€9,494
Receivables within one year -€556
Trade debts +€417
Cash 2025 €9,553
brings cash intakes cash out
Every line side by side 23 lines
Line Code 2024 2025 Change %
Total assets 20/58 €19,709 €10,632 -€9,077 -46.1%
Current assets 29/58 €19,709 €10,632 -€9,077 -46.1%
Amounts receivable within one year 40/41 €523 €1,079 +€556 +106%
Other amounts receivable 41 €523 €1,079 +€556 +106%
Cash at bank and in hand 54/58 €19,186 €9,553 -€9,633 -50.2%
Total equity and liabilities 10/49 €19,709 €10,632 -€9,077 -46.1%
Equity 10/15 €19,709 €10,215 -€9,494 -48.2%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €860 - -€860
Distributable reserves 133 €860 - -€860
Profit (loss) carried forward 14 €249 -€8,385 -€8,634
Amounts payable 17/49 - €417 +€417
Amounts payable within one year 42/48 - €417 +€417
Trade debts 44 - €417 +€417
Suppliers 440/4 - €417 +€417
Other operating charges 640/8 €636 €654 +€19 +2.9%
Gross operating margin 9900 -€4,289 -€8,668 -€4,379 -102%
Operating profit (loss) 9901 -€4,925 -€9,322 -€4,397 -89.3%
Financial charges 65/66B €138 €172 +€34 +24.6%
Recurring financial charges 65 €138 €172 +€34 +24.6%
Profit (loss) for the period before taxes 9903 -€5,063 -€9,494 -€4,431 -87.5%
Profit (loss) for the period 9904 -€5,063 -€9,494 -€4,431 -87.5%
Profit (loss) for the period to be appropriated 9905 -€5,063 -€9,494 -€4,431 -87.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.